The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene
Open accessAbstract
Genetic risk for multiple sclerosis (MS) is thought to involve both common and rare risk alleles. Recent GWAS and subsequent meta-analysis have established the critical role of the HLA locus and identified new common variants associated to MS. These variants have small odds ratios (ORs) and explain only a fraction of the genetic risk. To expose potentially rare, high-impact alleles, we conducted a GWAS of 68 distantly related cases and 136 controls from a high-risk internal isolate of Finland with increased prevalence and familial occurrence of MS. The top 27 loci with p < 10(-4) were tested in 711 cases and 1029 controls from Finland, and the top two findings were validated in 3859 cases and 9110 controls from more heterogeneous populations. SNP (rs744166) within the STAT3 gene was associated to MS (p = 2.75 x 10(-10), OR 0.87, confidence interval 0.83-0.91). The protective haplotype for MS in STAT3 is a risk allele for Crohn disease, implying that STAT3 represents a shared risk locus for at least two autoimmune diseases. This study also demonstrates the potential of special isolated populations in search for variants contributing to complex traits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“by 2011, common variants in 26 genomic loci had been associated with MS risk and independently replicated”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [38]
In the citing paper
“One example is rs744166 (located in an intron of the STAT3 gene on chromosome 17): the G allele is associated with increased risk in MS38 and decreased risk in Crohn's disease.71”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [38]
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Self-citationHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,551
Self-citationA second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,714
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Self-citationAnderson, E. N. (1977) · eScholarship (California Digital Library) · Cited by 2,567
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N. N., Freeman, A. F., Demidowich, A. P., Davis, J., Turner, M. L. C., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,230
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saitō, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pašić, S., Stojković, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,075
Cited by
Sorted by citations
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O’Shea, J. J., & Plenge, R. M. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,176
Hillmer, E. J., Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.001 · Cited by 740
New IBD genetics: common pathways with other diseases
Lees, C. W., Barrett, J. C., Parkes, M., & Satsangi, J. (2011) · Gut · doi:10.1136/gut.2009.199679 · Cited by 635
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Flanagan, S. E., Haapaniemi, E. M., Russell, M. A., Caswell, R. C., Allen, H. L., Franco, E. D., McDonald, T. J., Rajala, H. L. M., Ramelius, A., Barton, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3040 · Cited by 521
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Self-citationSawcer, S. J., Franklin, R. J. M., & Ban, M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70041-9 · Cited by 432
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
Patsopoulos, N. A., the Bayer Pharma MS Genetics Working Group, T. S. C. O. S. E. I. A. A. C., & de Bakker, P. I. W. (2011) · Annals of Neurology · doi:10.1002/ana.22609 · Cited by 353
The genetics of multiple sclerosis: an up‐to‐date review
Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01134.x · Cited by 294
Self-citationQin, H., Yeh, W.-I., Sarno, P. D., Holdbrooks, A. T., Liu, Y., Muldowney, M., Reynolds, S. L., Yanagisawa, L. L., Fox, T. H., Park, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117218109 · Cited by 271
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
Baranzini, S. E., & Oksenberg, J. R. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.09.004 · Cited by 264
Common genetic variation influencing human white matter microstructure
Zhao, B., Li, T., Yang, Y., Wang, X., Luo, T., Shan, Y., Zhu, Z., Xiong, D., Hauberg, M. E., Bendl, J. M., et al. (2021) · Science · doi:10.1126/science.abf3736 · Cited by 222
Sun, L., He, C., Nair, L., Yeung, J., & Egwuagu, C. E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.030 · Cited by 246
Functions and regulation of T cell-derived interleukin-10
Neumann, C., Scheffold, A., & Rutz, S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101344 · Cited by 208
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Mitrovič, M., Patsopoulos, N. A., Beecham, A. H., Dankowski, T., Goris, A., Dubois, B., D'hooghe, M. B., Lemmens, R., Damme, P. V., Søndergaard, H. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.049 · Cited by 179
Self-citationGenetics of Multiple Sclerosis: An Overview and New DirectionsPreprint
Patsopoulos, N. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028951 · Cited by 188
Advances in the immunopathogenesis of multiple sclerosis
Yadav, S. K., Mindur, J. E., Ito, K., & Dhib-Jalbut, S. S. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000205 · Cited by 173
Baranzini, S. E., Khankhanian, P., Patsopoulos, N. A., Li, M., Stankovich, J. M., Cotsapas, C. J., Søndergaard, H. B., Ban, M., Barizzone, N., Bergamaschi, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.019 · Cited by 162
Self-citationLiu, Y., Holdbrooks, A. T., Sarno, P. D., Rowse, A. L., Yanagisawa, L. L., McFarland, B. C., Harrington, L. E., Raman, C., Sabbaj, S., Benveniste, E. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301513 · Cited by 155
Schneider, A., Long, S. A., Cerosaletti, K. M., Ni, C., Samuels, P. L., Kita, M., & Buckner, J. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004970 · Cited by 157
Ma, W.-T., Chang, C. C.-C., Gershwin, M. E., & Lian, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.003 · Cited by 146
Genetic Epidemiology of Psoriasis
Gupta, R., Debbaneh, M. G., & Liao, W. J. (2014) · Current Dermatology Reports · doi:10.1007/s13671-013-0066-6 · Cited by 139
Multiple sclerosis genetics—is the glass half full, or half empty?
Oksenberg, J. R., & Baranzini, S. E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.91 · Cited by 138
Rubicz, R. C., Yolken, R. H., Drigalenko, E. I., Carless, M. A., Dyer, T. D., Bauman, L., Melton, P. E., Kent, J. W., Harley, J. B., Curran, J. E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003147 · Cited by 118
Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients
Paraboschi, E. M., Soldà, G., Gemmati, D., Orioli, E., Zeri, G., Benedetti, M. D., Salviati, A., Barizzone, N., Leone, M., Duga, S., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128695 · Cited by 102
Benveniste, E. N., Liu, Y., McFarland, B. C., & Qin, H. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0012 · Cited by 117
Axisa, P., & Hafler, D. A. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000319 · Cited by 126
Self-citationGenome-wide association study implicates NDST3 in schizophrenia and bipolar disorder
Lencz, T., Guha, S., Liu, C., Rosenfeld, J., Mukherjee, S., DeRosse, P., John, M., Cheng, L., Zhang, C., Badner, J. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3739 · Cited by 111
Systematic review of genome-wide expression studies in multiple sclerosis
Kemppinen, A. K., Kaprio, J. A., Palotie, A. V., & Saarela, J. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000053 · Cited by 111
Self-citationIreland, S. J., Monson, N. L., & Davis, L. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.009 · Cited by 105
Hundhausen, C., Roth, A., Whalen, E., Chen, J., Schneider, A., Long, S. A., Wei, S., Rawlings, R., Kinsman, M., Evanko, S. P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9943 · Cited by 104
A Polygenic Approach to the Study of Polygenic Diseases
Lvovs, D., Favorova, O. O., & Favorov, A. V. (2012) · Acta Naturae · doi:10.32607/20758251-2012-4-3-59-71 · Cited by 101
Evolutionary evidence of the effect of rare variants on disease etiology
Gorlov, I. P., Gorlova, O., Frazier, M., Spitz, M. R., & Amos, C. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01535.x · Cited by 110
Aggregation of multiple sclerosis genetic risk variants in multiple and single case families
Gourraud, P., McElroy, J. P., Caillier, S. J., Johnson, B. A., Santaniello, A., Hauser, S. L., & Oksenberg, J. R. (2010) · Annals of Neurology · doi:10.1002/ana.22323 · Cited by 100
Self-citationInflammatory bowel disease: An increased risk factor for neurologic complications
Morís, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1228 · Cited by 97
STAT3 in Skeletal Muscle Function and Disorders
Guadagnin, E., Mázala, D. A. G., & Chen, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082265 · Cited by 92
Genome‐wide association studies in Crohn's disease: Past, present and future
Verstockt, B., Smith, K. G. C., & Lee, J. C. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1001 · Cited by 97
Bashinskaya, V. V., Кулакова, О. Г., Boyko, A. N., Favorov, A. V., & Favorova, O. O. (2015) · Human Genetics · doi:10.1007/s00439-015-1601-2 · Cited by 101
Giussani, P., Prinetti, A., & Tringali, C. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15133 · Cited by 91
Genome‐wide association studies of multiple sclerosis
Cotsapas, C., & Mitrovic, M. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1018 · Cited by 89
A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis
Field, J., Browning, S. R., Johnson, L., Danoy, P., Varney, M. D., Tait, B. D., Gandhi, K. S., Charlesworth, J., Heard, R. N., Stewart, G. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013454 · Cited by 88
Identification of Novel Autoantibodies Associated With Psoriatic Arthritis
Yuan, Y., Qiu, J., Lin, Z., Li, W., Haley, C. T., Mui, U. N., Ning, J., Tyring, S. K., & Wu, T. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40830 · Cited by 86
The genetics of multiple sclerosis: An update 2010
Hoffjan, S., & Akkad, D. A. (2010) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2010.04.006 · Cited by 81
MicroRNAs and Multiple Sclerosis
Tüfekçi, K. U., Öner, M. G., Genç, Ş., & Genç, K. (2010) · Autoimmune Diseases · doi:10.4061/2011/807426 · Cited by 83
Cotsapas, C. J., Mitrovič, M., & Hafler, D. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00046-6 · Cited by 88
Self-citationIL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
(IMSGC), T. I. M. S. G. C. (2010) · Genes and Immunity · doi:10.1038/gene.2010.28 · Cited by 82
Role of genetics in the diagnosis and prognosis of Crohn's disease
Tsianos, E. V. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i2.105 · Cited by 78
Liu, X., Zhou, F., Yang, Y., Wang, W., Niu, L., Zuo, D., Li, X., Hua, H., Zhang, B., Kou, Y., et al. (2018) · Glia · doi:10.1002/glia.23530 · Cited by 76
The International Multiple Sclerosis Genetics Consortium (2011) · PLoS ONE · doi:10.1371/journal.pone.0018813 · Cited by 74
The genetics of multiple sclerosis: review of current and emerging candidates
Otaegui, D., Muñoz-Culla, & Irizar, H. (2013) · The Application of Clinical Genetics · doi:10.2147/tacg.s29107 · Cited by 78
Genetics of autoimmune diseases: perspectives from genome-wide association studies
Kochi, Y. (2016) · International Immunology · doi:10.1093/intimm/dxw002 · Cited by 76
Genetic predisposition to autoimmunity – What have we learned?
Rai, E., & Wakeland, E. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.015 · Cited by 73
Ma, G. Z. M., Stankovich, J. M., Kilpatrick, T. J., Binder, M. D., & Field, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016964 · Cited by 70
Lu, H. C., Kim, S.-J., Steelman, A. J., Tracy, K., Zhou, B., Michaud, D., Hillhouse, A., Konganti, K., & Li, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913997117 · Cited by 70
Decoding multiple sclerosis: an update on genomics and future directions
Oksenberg, J. R. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.865867 · Cited by 66
Genetic risk variants in African Americans with multiple sclerosis
Isobe, N., Gourraud, P., Harbo, H. F., Caillier, S. J., Santaniello, A., Khankhanian, P., Maiers, M. J., Spellman, S. R., Cereb, N., Yang, S., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfe2f · Cited by 64
Self-citationGlas, J., Seiderer, J., Nagy, M. S., Fries, C., Beigel, F., Weidinger, M., Pfennig, S., Klein, W., Epplen, J. T., Lohse, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010373 · Cited by 63
Xie, J., Zhang, Y., Zhang, Q., Han, Y., Yin, J., Pu, R., Shen, Q., Lu, W., Du, Y., Zhao, J., et al. (2013) · Hepatology · doi:10.1002/hep.26303 · Cited by 63
Cree, B. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00009-1 · Cited by 62
Cianciulli, A., Calvello, R., Porro, C., Trotta, T., & Panaro, M. A. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.07.005 · Cited by 59
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 60
Genetic basis of rheumatoid arthritis: A current review
Kochi, Y., Suzuki, A., & Yamamoto, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.085 · Cited by 58
Revealing the genetic basis of multiple sclerosis: are we there yet?
Baranzini, S. E. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.006 · Cited by 58
Therapeutic targeting of STAT pathways in CNS autoimmune diseases
Egwuagu, C. E., & Larkin, J. (2013) · JAK-STAT · doi:10.4161/jkst.24134 · Cited by 55
Activation pathways that drive CD4 + T cells to break tolerance in autoimmune diseases*
Krovi, S. H., & Kuchroo, V. K. (2022) · Immunological Reviews · doi:10.1111/imr.13071 · Cited by 53
Yan, Z., Yang, W., Parkitny, L., Gibson, S. A., Lee, K. S., Collins, F., Deshane, J. S., Cheng, W., Weinmann, A. S., Wei, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126520 · Cited by 58
JAK2 and STAT3 Polymorphisms in a Han Chinese Population with Behçet's Disease
Hu, K., Hou, S., Jiang, Z., Kijlstra, A., & Yang, P. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8440 · Cited by 50
The genetics of multiple sclerosis
Lin, R., Charlesworth, J., van der Mei, I. A. F., & Taylor, B. V. (2012) · Practical Neurology · doi:10.1136/practneurol-2012-000276 · Cited by 51
Genetic determinants of risk and progression in multiple sclerosis
Didonna, A., & Oksenberg, J. R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.034 · Cited by 49
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
Berge, T., Leikfoss, I., & Harbo, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034476 · Cited by 45
Self-citationA novel class of somatic mutations in blood detected preferentially in CD8 + cells
Valori, M., Jansson, L., Kiviharju, A., Ellonen, P., Rajala, H. L. M., Awad, S. A., Mustjoki, S. M., & Tienari, P. J. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.018 · Cited by 42
Self-citationŠedivá, H., Dušátková, P., Kanderová, V., Obermannová, B., Kayserová, J., Šrámková, L., Zemkova, D., Elblová, L., Svaton, M., Zachová, R., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000456544 · Cited by 44
Hiltensperger, M., & Korn, T. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029637 · Cited by 45
Somatic Variants: New Kids on the Block in Human Immunogenetics
Horebeek, L. V., Dubois, B., & Goris, A. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.09.005 · Cited by 46
Alhazzani, K., Ahmad, S. F., Al-Harbi, N. O., Attia, S. M., Bakheet, S. A., Sarawi, W. S., Alqarni, S. A., Algahtani, M., & Nadeem, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070925 · Cited by 42
Liu, Y., Gibson, S. A., Benveniste, E. N., & Qin, H. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016015517 · Cited by 43
Targeting STATs in neuroinflammation: The road less traveled!
Nabavi, S. M., Ahmed, T., Nawaz, M., Devi, K. P., Balan, D. J., Pittalà, V., Argüelles, S., Testai, L., Khan, H. Z., Sureda, A., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.004 · Cited by 41
Genetic burden in multiple sclerosis families
Isobe, N., Damotte, V., Re, V. L., Ban, M., Pappas, D. J., Guillot‐Noël, L., Cournu‐Rebeix, I., Compston, A., Mack, T. M., Cozen, W., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.37 · Cited by 38
Self-citationThe Genetics of Multiple Sclerosis
Didonna, A., & Oksenberg, J. R. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch1 · Cited by 44
Xiao, L., Muhali, F.-S., Cai, T., Song, R., Hu, R., Shi, X., Jiang, W., Li, D.-F., He, S., Xu, J., et al. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0337-0 · Cited by 38
Epistasis and immunity: the role of genetic interactions in autoimmune diseases
Rose, A. M., & Bell, L. C. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03623.x · Cited by 40
Genetics of multiple sclerosis
Hoppenbrouwers, I. A., & Hintzen, R. Q. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.017 · Cited by 39
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
Paraboschi, E. M., Cardamone, G., Soldà, G., Duga, S., & Asselta, R. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00647 · Cited by 37
Environmental Influencers, MicroRNA, and Multiple Sclerosis
Mohammed, E. M. A. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573519894955 · Cited by 39
Multiple sclerosis is prominent in the Gulf states: Review
Mohammed, E. M. A. (2016) · Pathogenesis · doi:10.1016/j.pathog.2016.04.001 · Cited by 37
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians
Sokolova, E. А., Malkova, N. A., Korobko, D. S., Rozhdestvenskiĭ, A. S., Kakulya, A. V., Ханох, Е. В., Ra, D., Платонов, Ф. А., Popova, T., Геннадьевна, А. Е., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061032 · Cited by 36
Handel, A. E., Handunnetthi, L., Berlanga‐Taylor, A. J., Watson, C. T., Morahan, J. M., & Ramagopalan, S. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010142 · Cited by 35
Genetics and functional genomics of multiple sclerosis
Kim, W., & Patsopoulos, N. A. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-021-00907-3 · Cited by 38
GWAS-identified multiple sclerosis risk loci involved in immune response: Validation in Russians
Bashinskaya, V. V., Кулакова, О. Г., Сергеевич, К. И., Baulina, N., Favorov, A. V., Boyko, A. N., Tsareva, E., & Favorova, O. O. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.015 · Cited by 33
Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity
Voight, B. F., & Cotsapas, C. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.013 · Cited by 33
Al‐Mazroua, H. A., Nadeem, A., Ansari, M. A., Attia, S. M., Bakheet, S. A., Albekairi, T. H., Ali, N., Alasmari, F. F., Algahtani, M., Alsaad, A. M. S., et al. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.02.017 · Cited by 34
Minashkin, M. M., Grigortsevich, N. Y., Kamaeva, A. S., Barzanova, V. V., Traspov, A., Godkov, M. A., Ageev, F. A., Petrikov, S. S., & Pozdnyakova, N. V. (2022) · Biomedicines · doi:10.3390/biomedicines10030549 · Cited by 31
Genome-wide association studies in neurology.
Tan, M., Jiang, T., Tan, L., & Yu, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.11.12 · Cited by 35
Mahurkar, S., Moldovan, M., Suppiah, V., & O'Doherty, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057655 · Cited by 22
Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases
Tavakolpour, S., Darvishi, M., & Ghasemiadl, M. (2017) · Clinical Genetics · doi:10.1111/cge.13186 · Cited by 32
Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications
Solouki, S., August, A., & Huang, W. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.008 · Cited by 37
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance
Aqel, S. I., Yang, X. T., Kraus, E. E., Song, J., Farinas, M. F., Zhao, E. Y., Pei, W., Lovett‐Racke, A. E., Racke, M. K., Li, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142376 · Cited by 32
Blankenhorn, E. P., Butterfield, R. J., Case, L. K., Wall, E. H., del Río, R., Diehl, S. A., Krementsov, D. N., Saligrama, N., & Teuscher, C. (2011) · Annals of Neurology · doi:10.1002/ana.22642 · Cited by 32
An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer
Ryan, B. M., Wolff, R. K., Valeri, N., Khan, M. A., Robinson, D., Paone, A., Bowman, E. D., Lundgreen, A., Caan, B. J., Potter, J. D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.07.003 · Cited by 31
Multiple Sclerosis Genetics 2010
McElroy, J. P., & Oksenberg, J. R. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.002 · Cited by 30
Lill, C. M., Schjeide, B. M., Akkad, D. A., Blaschke, P., Winkelmann, A., Gerdes, L.-A., Hoffjan, S., Luessi, F., Dörner, T., Li, S., et al. (2011) · Neurogenetics · doi:10.1007/s10048-011-0305-6 · Cited by 30
Metadata
- Authors
- Jakkula, E., Leppä, V., Sulonen, A.-M., Varilo, T., Kallio, S., Kemppinen, A., Purcell, S., Koivisto, K., Tienari, P., Sumelahti, M.-L., Elovaara, I., Pirttilä, T., Reunanen, M., Aromaa, A., Oturai, A. B., Søndergaard, H. B., Harbo, H. F., Mero, I.-L., Gabriel, S. B., Mirel, D. B., Hauser, S. L., Kappos, L., Polman, C., De Jager, P. L., Hafler, D. A., Daly, M. J., Palotie, A., Saarela, J., & Peltonen, L.
- Affiliations
- Broad Institute (US)
- University of Helsinki (FI)
- Seinäjoen Keskussairaala (FI)
- Tampere University (FI)
- Tampere University Hospital (FI)
- Kuopio University Hospital (FI)
- Oulu University Hospital (FI)
- Finnish Institute for Health and Welfare (FI)
- Copenhagen University Hospital (DK)
- Oslo University Hospital (NO)
- University of California, San Francisco (US)
- University of Basel (CH)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Brigham and Women's Hospital (US)
- Corresponding author
- Peltonen, Leena
- ORCID
- Jakkula, Eveliina
- Leppä, Virpi
- Sulonen, Anna-Maija
- Varilo, Teppo
- Kemppinen, Anu
- Purcell, Shaun
- Tienari, Pentti
- Sumelahti, Marja-Liisa
- Søndergaard, Helle Bach
- Harbo, Hanne F.
- Mero, Inger-Lise
- Gabriel, Stacey B.
- Hauser, Stephen L.
- Kappos, Ludwig
- Polman, Chris
- Hafler, David A.
- Daly, Mark J.
- Palotie, Aarno
- Saarela, Janna
- Peltonen, Leena
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 86
- Issue
- 2
- Pages
- 285-291
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC2820168
- OpenAlex
- W2097780447
- Cited by
- 245
- References
- 56
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 17 · 2020: 15 · 2019: 14 · 2018: 13 · 2017: 11 · 2016: 12 · 2015: 19 · 2014: 25 · 2013: 29 · 2012: 16
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (089061/Z/09/Z)
- National Institutes of Health (6u54rr020278-06)
- National Institute of Mental Health (R01MH071425)
- National Institute of Neurological Disorders and Stroke (R01NS43559, R01NS043559)
- National Center for Research Resources (U54-RR020278)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic risk, rare variants, Finnish population, haplotypes, Crohn's disease, autoimmune disease, HLA locus
- MeSH terms
- Alleles, Genetics, Population, Haplotypes, Humans, Multiple Sclerosis, Reproducibility of Results, Linkage Disequilibrium, Case-Control Studies, Genetic Predisposition to Disease, Base Pairing, Polymorphism, Single Nucleotide, STAT3 Transcription Factor, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review